--- Chain 1 for Question 158 ---
Status: PRUNED
Is Active Flag: False
Finish Reason: worker_terminated_unexpectedly
Reasoning Complete Flag: True
Error: None
Prompt Tokens: 210
Completion Tokens: 494
Completed Thoughts: 3
Pruned at Analysis Step: 4
Final Processed Boundaries: [0, 365, 647]

--- Full Content ---
Alright, so I've got this question about transcription factors and mutations. Hmm, let me try to break it down.

Okay, the question is about two mutations: X and Y. X is a missense mutation in the transactivation domain and is a recessive loss-of-function mutation. Y is a heterozygous mutation in the dimerization domain and acts as a dominant-negative mutation.

Wait, what's a missense mutation? Oh right, it's a point mutation that changes one amino acid to another. Since X is recessive loss-of-function, that means the mutant allele can't function unless both copies are mutated. So in a heterozygote, the wild-type allele would still work. But wait, X is in the transactivation domain where phosphorylation happens, right? Because the question says that when the transcription factor is phosphorylated on Ser residues in that domain, it dimerizes and goes into the nucleus.

Now, Y is a dominant-negative mutation in the dimerization domain. Dominant-negative means that the mutant protein interferes with the function of the wild-type protein. Since Y is in the dimerization domain, which is necessary for the subunits to come together, the mutant might prevent proper dimerization.

So the question is, what's the molecular phenotype when mutation Y is present?

The options are A to D. Let me think about each.

Option A: Change of protein conformation and gain-of-function. Hmm, dominant-negative usually leads to loss of function, not gain. So maybe not A.

Option B: Protein degradation and loss of wild-type. Well, dominant-negative mutations don't necessarily cause degradation. They might interfere with function. So I'm not sure about B, but protein degradation could be due to something like a ubiquitin tag but I don't think that's Y's effect here.

Option C: Loss of dimerization and wild-type phenotype. Wait, if Y is dominant-negative, then when Y is present in a heterozygote (so one wild-type and one Y), the Y mutant might prevent the wild-type from dimerizing. So the wild-type can't function because it can't form dimers. So Y would cause a loss of function, but C says the wild-type phenotype, which doesn't make sense. Because the presence of Y would disrupt the function.

Option D: Protein aggregation and loss of function. Aggregation could happen if the